Survival outcomes in US patients with metastatic colorectal cancer (mCRC)

被引:1
|
作者
Knopf, Kevin
Iqbal, Sheikh Usman
Thompson, Stephen F.
Malangone, Elisabetta
Gorritz-Kindu, Magdaliz
Stern, Lee
Sherman, Steven A.
Naoshy, Sarah
Wooten, Michael
Andria, Michael L.
机构
[1] Pacif Hematol Oncol Associates, San Francisco, CA USA
[2] Sanofi, Cambridge, MA USA
[3] Sanofi, Bridgewater, NJ USA
[4] Analytica LA SER Int Inc, New York, NY USA
[5] Regeneron Pharmaceut, Dacula, GA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1200/jco.2013.31.4_suppl.559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
559
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability.
    Price, Timothy Jay
    Karapetis, Christos Stelios
    Joanne, Young
    Roy, Amitesh
    Padbury, Rob
    Maddern, Guy
    Moore, James
    Piantadosi, Cynthia
    Roder, David
    Townsend, Amanda Rose
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [22] Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
    Boland, Patrick M.
    Quintanilha, Julia
    Li, Gerald
    Clark, Allison
    Carlson, Erik
    Morley, Samantha
    Aboosaiedi, Ali
    Mitchell, Jerry W.
    Ross, Jeffrey S.
    Graf, Ryon
    Deming, Dustin A.
    Lieu, Christopher Hanyoung
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 207 - 207
  • [23] TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING
    Cartwright, T. H.
    Pan, I
    Wen, L.
    Wadlow, R. C.
    Rembert, D.
    Seal, B.
    VALUE IN HEALTH, 2014, 17 (03) : A69 - A70
  • [24] Clinicopathological characteristics and outcomes of young patients (YP) with metastatic colorectal cancer (mCRC) in Australia.
    Lee, Margaret
    Turner, Natalie Heather
    Wong, Hui-Li
    Aung, Soe Yu
    RAi, Rajat
    Maddison, Claire
    Morris, Kortnye
    Nott, Louise M.
    Yip, Desmond
    Field, Kathryn Maree
    Shapiro, Jeremy David
    Tie, Jeanne
    Tran, Ben
    Wong, Rachel
    Ananda, Sumitra
    Stefanou, Greg
    Jennens, Ross
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Predictors of treatment attrition in patients with metastatic colorectal cancer (mCRC).
    Bahrabadi, Arvin
    Ruan, Jenny
    Gresham, Gillian
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer
    Koroukian, Siran M.
    Booker, Benjamin D.
    Vu, Long
    Schumacher, Fredrick R.
    Rose, Johnie
    Cooper, Gregory S.
    Selfridge, J. Eva
    Markt, Sarah C.
    JAMA NETWORK OPEN, 2023, 6 (01) : E2250030
  • [27] Survival outcome in HER2-amplified metastatic colorectal cancer (mCRC).
    Sawada, Kentaro
    Okamoto, Wataru
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Fujii, Satoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
    He, Kuifeng
    Cui, Binbin
    Li, Guangliang
    Wang, Haohao
    Jin, Ketao
    Teng, Lisong
    ONCOTARGETS AND THERAPY, 2012, 5 : 59 - 65
  • [29] Primary tumor location and survival in general population with metastatic colorectal cancer (mCRC)
    Ahmed, Shahid
    Papneja, Neha
    Emara, Mohamed Elsayed
    Alvi, Riaz
    Asif, Tehmina
    Dorie-Anna, Dueck
    Le, Duc
    Zaidi, Adnan
    Haider, Kamal
    Kanthan, Selliah
    Iqbal, Nayyer
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [30] Survival benefit and clinical characteristics of patients with metastatic colorectal cancer (mCRC) receiving pulmonary metastasectomy.
    Alsar, Javier Soto
    Rodriguez, Roberto Jimenez
    Beranek, Marianela Bringas
    Alonso, Natalia Gutierrez
    Lozano, Rocio Martin
    Caraballo, Irene Gonzalez
    Perez, Sara Perez
    Casaurran, Guillermo Gonzalez
    Munoz, Andres
    Moran, Laura Ortega
    Calvo, Aitana
    Perez-Solero, Gabriela Torres
    Martin, Miguel
    Adiego, Carlos Maria Simon
    Garcia-Alfonso, Pilar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 59 - 59